CD57 / B3GAT1 (NK/804), 0.2mg/mL

Catalog number BNUB0804-100

Price for BNUB0804-100

Size / count 1x 100 µL

About this product

Anti-CD57 marks a subset of lymphocytes known as natural killer (NK) cells. Follicular center cell lymphomas often contain many NK cells within the neoplastic follicles. Anti-CD57 also stains neuroendocrine cells and their derived tumors, including carcinoid tumor and medulloblastoma. Anti-CD57 can also be useful in separating type B3 thymoma from thymic carcinoma when combined with a panel that includes antibodies against GLUT1, CD5, and CEA.This antibody is available purified with BSA/azide at 200 ug/mL, or BSA/azide-free at 1 mg/mL.

Specifications

Catalog number: BNUB0804-100
Size / count: 1x 100 µL
Dry ice: No
Hazardous: No
Discontinued: No
CAS Number: 9007-83-4
Synonyms: 3-Glucuronyltransferase 1; B3GAT1; Galactosylgalactosylxylosylprotein 3-beta-Glucuronosyltransferase 1; GLCATP; GlcUAT-P; Glucuronosyltransferase P; UDP GlcUA Glycoprotein beta 1, 3 Glucuronyltransferase
UNSPSC: 41116161
UNSPSC Description: Primary and secondary antibodies for multiple methodology immunostaining detection application
Gene Name: B3GAT1
Gene ID: 27087
NCBI Gene ID: 381050
UniProt: Q9P2W7
Swiss Prot: Q9P2W7
Host: Mouse
Species Reactivity: Human
Reactivity: B3GAT1|CD57
Immunogen: Recombinant human B3GAT1 protein
Target Antigen: B3GAT1 | CD57
Clonality: Monoclonal
Clone: NK/804
Type: Primary
Source: Animal
Origin: Animal
Applications: IHC, FFPE (verified)
Field of Research: Cancer, Immunology
Positive Control: Lymph node or Tonsil
Stability: 2 years
Concentration: 0.2 mg/mL
Buffer: PBS, 0.05% BSA, 0.05% azide
Molecular Weight: ~110 kDa
Shipping Conditions: RT (ND)
Storage Conditions: Stable at room temperature or 37°C (98°F) for 7 days.
Shelf Life: Guaranteed for at least 24 months from date of receipt when stored as recommended
Fragment: IgM, kappa
Species: Mus musculus (mouse), BSA from bovine serum (Bos taurus) or recombinant BSA produced in Chinese hamster ovary cells.
Classification: PBS, 0.05% BSA, 0.05% sodium azide (CAS 26628-22-8)
Conjugate: Purified, with BSA

Frequently Asked Questions

What is the catalog number for CD57 / B3GAT1 (NK/804), 0.2mg/mL?

The catalog number for CD57 / B3GAT1 (NK/804), 0.2mg/mL is BNUB0804-100.

What sizes are available for CD57 / B3GAT1 (NK/804), 0.2mg/mL?

CD57 / B3GAT1 (NK/804), 0.2mg/mL is available in the following size(s): 1x 100 µL.

Is CD57 / B3GAT1 (NK/804), 0.2mg/mL in stock?

CD57 / B3GAT1 (NK/804), 0.2mg/mL is currently made to order / not held in immediate stock. Contact us for lead time.

Who manufactures CD57 / B3GAT1 (NK/804), 0.2mg/mL?

CD57 / B3GAT1 (NK/804), 0.2mg/mL is manufactured by Biotium.

What is the estimated delivery time for CD57 / B3GAT1 (NK/804), 0.2mg/mL?

Estimated delivery time for CD57 / B3GAT1 (NK/804), 0.2mg/mL is approximately 15 business day(s), depending on your location.

Where can I find the safety data sheet (SDS/MSDS) for CD57 / B3GAT1 (NK/804), 0.2mg/mL?

The safety data sheet for CD57 / B3GAT1 (NK/804), 0.2mg/mL is available here: https://biotium.com/wp-content/uploads/2018/06/SDS-primary-antibodies.pdf.

What is CD57 / B3GAT1 (NK/804), 0.2mg/mL used for?

What is the shelf life of this product?

Shelf life and expiration dates vary by product and are shown on the product listing and label. Products used beyond their expiration date are not eligible for performance-related returns or refunds, so please check the lot number and expiry before use.

What expression system was used for this recombinant protein?

The expression system, such as E. coli, HEK293, or insect cells, is listed on the datasheet under production details, which can affect post-translational modifications relevant to your application.

Can I return this product if I ordered the wrong one?

As a consumer, you have a 14-day right of withdrawal from receipt under EU consumer protection law, submitted via our withdrawal/cancellation request form. Note this applies to unused, undamaged products, and doesn’t override the expiry/storage conditions on performance-based claims.